AI assistant
Sending…
ARTIVION, INC. — Director's Dealing 2017
Feb 24, 2017
31684_dirs_2017-02-24_4b3183ff-ebe1-4577-80f3-2538205b792f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2017-02-22
Reporting Person: Capps Scott B (VP, Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-22 | Common Stock | M | 16667 | $7.01 | Acquired | 128477 | Direct |
| 2017-02-22 | Common Stock | S | 11083 | $16.4013 | Disposed | 117394 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-22 | Stock Options (Right to Buy) | $7.01 | M | 16667 | Disposed | 2017-02-22 | Common Stock (16667) | Direct |
Footnotes
F1: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011
F2: Reflects weighted average price. Range was $16.35 to $16.45 The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
More from ARTIVION, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3